Literature DB >> 25861347

Agranulocytosis induced by ethambutol in a patient with pulmonary tuberculosis.

Kyoung Min Moon1, Min Soo Han1, So Hee Chung1, Ju Ri Kim1, Jin Young Kim1, Sun Young Jung1, Yongseon Cho1.   

Abstract

We report a case of agranulocytosis caused by ethambutol in a 79-year-old man with pulmonary tuberculosis. He was referred for fever and skin rash developed on 21th day after antituberculosis drugs (isoniazid, rifampicin, ethambutol, and pyrazinamide) intake. Complete blood count at the time of diagnosis of pulmonary tuberculosis was normal. On the seventh admission day, agranulocytosis was developed with absolute neutrophil count of 70/µL. We discontinued all antituberculosis drugs, and then treated with granulocyte colony-stimulating factor. Three days later, the number of white blood cell returned to normal. We administered isoniazid, pyrazinamide, and ethambutol in order with an interval. However, fever and skin rash developed again when adding ethambutol, so we discontinued ethambutol. After these symptoms disappeared, we added rifampicin and ethambutol in order with an interval. However after administering ethambutol, neutropenia developed, so we discontinued ethambutol again. He was cured with isoniazid, rifampicin, and pyrazinamide for 9 months.

Entities:  

Keywords:  Agranulocytosis; Ethambutol; Tuberculosis, Pulmonary

Year:  2015        PMID: 25861347      PMCID: PMC4388896          DOI: 10.4046/trd.2015.78.2.125

Source DB:  PubMed          Journal:  Tuberc Respir Dis (Seoul)        ISSN: 1738-3536


  7 in total

1.  Agranulocytosis and anaemia associated with disseminated tuberculosis.

Authors:  P E TATTERSALL
Journal:  Br Med J       Date:  1957-12-07

Review 2.  Ethambutol: a review with special reference to ocular toxicity.

Authors:  K M Citron
Journal:  Tubercle       Date:  1969-03

3.  Ethambutol-induced neutropenia and eosinophilia.

Authors:  C F Wong; W W Yew
Journal:  Chest       Date:  1994-11       Impact factor: 9.410

4.  Adverse effects of antituberculosis drugs.

Authors:  D J Girling
Journal:  Drugs       Date:  1982 Jan-Feb       Impact factor: 9.546

5.  Neutropenia with each standard antituberculosis drug in the same patient.

Authors:  P F Jenkins; T D Williams; I A Campbell
Journal:  Br Med J       Date:  1980-04-19

6.  Adverse effects of antitubercular drugs and significance of measurement of the drug-stimulating lymphocyte transformation rate.

Authors:  S Umeki
Journal:  Jpn J Med       Date:  1989 May-Jun

Review 7.  [Agranulocytosis due to anti-tuberculosis drugs including isoniazid (INH) and rifampicin (RFP)--a report of four cases and review of the literature].

Authors:  Yuichiro Shishido; Naohiro Nagayama; Kimihiko Masuda; Motoo Baba; Atsuhisa Tamura; Hideaki Nagai; Shinobu Akagawa; Yoshiko Kawabe; Kazuko Machida; Atsuyuki Kurashima; Hikotaro Komatsu; Hideki Yotsumoto
Journal:  Kekkaku       Date:  2003-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.